TRAJECTORY OF CARIPRAZINE TREATMENT EFFECTS ACROSS SCHIZOPHRENIA SYMPTOMS: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL

被引：0
|
作者：
Cutler, Andrew J. [1 ]
Durgam, Suresh [2 ]
Lu, Kaifeng [2 ]
Ruth, Adam [3 ]
Laszlovszky, Istvan [4 ]
Nemeth, Gyoergy [4 ]
Meltzer, Herbert Y. [5 ]
机构：
[1] Florida Clin Res Ctr LLC, Bradenton, IL USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
[4] Gedeon Richter Plc, Budapest, Hungary
[5] Northwestern Feinberg Sch Med, Chicago, IL USA
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
2086005
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [41] Response to Letter to Regarding Article, "Effects of Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial"
    Calhoun, David A.
    White, William B.
    Krum, Henry
    Guo, Weinong
    Trapani, Angelo
    Lefkowitz, Martin P.
    Bermann, Georgina
    Menard, Joel
    CIRCULATION, 2012, 125 (18) : E654 - E654
  • [42] Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial
    Mazinani, Robabeh
    Nejati, Somayeh
    Khodaei, Mohammadreza
    PSYCHIATRY RESEARCH, 2017, 247 : 291 - 295
  • [43] Effect of ritanserin on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Malek-Hosseini, Mojgan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 304
  • [44] Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day-A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia
    Coppola, Danielle
    Melkote, Rama
    Lannie, Caroline
    Singh, Jaskaran
    Nuamah, Isaac
    Gopal, Srihari
    Hough, David
    Palumbo, Joseph
    PSYCHOPHARMACOLOGY BULLETIN, 2011, 44 (02) : 54 - 72
  • [45] Efficacy of cariprazine in negative, cognitive, and social function symptoms in schizophrenia: post hoc analysis of a randomized, controlled trial
    Cutler, A. J.
    Durgam, S.
    Lu, K.
    Laszlovszky, I.
    Szalai, E.
    Edwards, J.
    Earley, W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S551 - S552
  • [46] Long-Term Cariprazine Treatment for the Prevention of Relapse in Patients with Schizophrenia: Additional Analysis from a Randomized, Double-Blind, Placebo-Controlled Trial
    Durgam, Suresh
    Earley, Willie
    Li, Rui
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Edwards, John
    Nasrallah, Henry
    Fleischhacker, W.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S380 - S381
  • [47] Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study
    Malik, M.
    van Gelderen, E. M.
    Lee, J. H.
    Kowalski, D. L.
    Yen, M.
    Goldwater, R.
    Mujais, S. K.
    Schaddelee, M. P.
    de Koning, P.
    Kaibara, A.
    Moy, S. S.
    Keirns, J. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (06) : 696 - 706
  • [48] Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety
    Markman, John D.
    Bolash, Robert B.
    McAlindon, Timothy E.
    Kivitz, Alan J.
    Pombo-Suarez, Manuel
    Ohtori, Seiji
    Roemer, Frank W.
    Li, David J.
    Viktrup, Lars
    Bramson, Candace
    West, Christine R.
    Verburg, Kenneth M.
    PAIN, 2020, 161 (09) : 2068 - 2078
  • [49] Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study
    Miller, Paul D.
    Chines, Arkadi A.
    Christiansen, Claus
    Hoeck, Hans C.
    Kendler, David L.
    Lewiecki, E. Michael
    Woodson, Grattan
    Levine, Amy B.
    Constantine, Ginger
    Delmas, Pierre D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (04) : 525 - 535
  • [50] A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata
    Trink, A.
    Sorbellini, E.
    Bezzola, P.
    Rodella, L.
    Rezzani, R.
    Ramot, Y.
    Rinaldi, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (03) : 690 - 694
12345